This stock comparison pits MS, a leading U.S.-based global investment bank with significant wealth management operations, against NMR, Japan's premier financial services firm focused on wholesale and retail banking in Asia. Investors and traders interested in financial sector exposure, particularly those weighing U.S. versus international markets, may find value in evaluating their relative performance amid volatile trading environments and recovering dealmaking activity. Recent earnings highlight contrasts in momentum, valuation, and regional drivers, aiding decisions on portfolio positioning or short-term trades.
Morgan Stanley (MS) operates as a global financial services giant, emphasizing institutional securities, investment banking (IB), and wealth management. In recent market activity, shares have climbed toward 52-week highs around $194, supported by robust first-quarter results including record equities trading revenue of $5.15 billion and IB fees up 36%. Wealth management showed momentum with NNA of $118 billion and fee-based asset flows of $54 billion, bolstering sentiment amid broader Wall Street gains. Trading above key moving averages, the stock reflects positive investor confidence in its diversified revenue streams and stablecoin initiatives, despite some private credit fund pressures earlier in the quarter.
Nomura Holdings (NMR) is a diversified Japanese financial group providing investment banking, wholesale services, and retail wealth management, with strong Asia-Pacific exposure. Fiscal year results ending March 31 highlighted record net revenue of ¥2.17 trillion (up 15%) and net income of ¥362 billion, driven by Japan's equity market recovery and steady wealth management growth. However, the final quarter saw softer pre-tax income (down 20% quarter-on-quarter), contributing to recent share pullbacks near $8. Trading with neutral technicals and a low beta of 0.61 (indicating lower volatility), NMR appeals for income via its 5% dividend yield, though momentum lags amid regional uncertainties.
Tickeron’s Trending AI Robots page curates the top 25 performers from over 350 AI trading bots designed for copy trading across thousands of tickers. These virtual agents deliver real-time signals with automated risk management, featuring annualized returns from +15% to +170%, win rates of 48%–88%, and profit factors up to 11.7. Strategies vary from swing trading and trend following on 5–60 minute timeframes to long/short ETFs in sectors like finance (including MS alongside peers), semiconductors, and energy. Ideal for current volatile conditions, they offer diverse styles with drawdowns managed via take-profit/stop-loss (e.g., 3%/2%). Explore these high-performing bots to enhance your trading edge.
Both MS and NMR thrive in investment banking and trading, but MS’s global wealth management (larger scale) contrasts NMR’s Asia-centric wholesale/retail focus. Growth drivers differ: MS leverages U.S. trading surges and IB rebound, while NMR benefits from Japanese market rallies. Recent momentum favors MS (+16% past month vs. NMR -2.5%), with bullish technicals versus neutral for NMR. Risk factors include MS’s exposure to private credit outflows and NMR’s yen volatility; sector-wise, both financials but MS (~$299B cap) dwarfs NMR ($22B). Sentiment tilts toward MS on earnings strength, trading at a growth premium over NMR’s value play.
Tickeron’s AI currently leans toward MS based on superior trend consistency, post-earnings stability, and bullish catalysts like record trading and wealth inflows. While NMR offers attractive valuation and dividends, its softer recent quarter and muted momentum suggest higher probability of near-term upside for MS in the prevailing environment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MS’s FA Score shows that 4 FA rating(s) are green whileNMR’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MS’s TA Score shows that 3 TA indicator(s) are bullish while NMR’s TA Score has 5 bullish TA indicator(s).
MS (@Investment Banks/Brokers) experienced а +4.18% price change this week, while NMR (@Investment Banks/Brokers) price change was -3.03% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -2.25%. For the same industry, the average monthly price growth was -2.75%, and the average quarterly price growth was -6.61%.
MS is expected to report earnings on Jul 15, 2026.
NMR is expected to report earnings on Jul 29, 2026.
These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
| MS | NMR | MS / NMR | |
| Capitalization | 357B | 25.4B | 1,406% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 29.313 | 2.980 | 984% |
| P/E Ratio | 20.57 | 12.23 | 168% |
| Revenue | 68.8B | 1.8T | 4% |
| Total Cash | 4.29B | N/A | - |
| Total Debt | 394B | 16.6T | 2% |
MS | NMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 7 | 34 | |
SMR RATING 1..100 | 7 | 3 | |
PRICE GROWTH RATING 1..100 | 9 | 43 | |
P/E GROWTH RATING 1..100 | 28 | 19 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NMR's Valuation (12) in the Investment Banks Or Brokers industry is significantly better than the same rating for MS (91). This means that NMR’s stock grew significantly faster than MS’s over the last 12 months.
MS's Profit vs Risk Rating (7) in the Investment Banks Or Brokers industry is in the same range as NMR (34). This means that MS’s stock grew similarly to NMR’s over the last 12 months.
NMR's SMR Rating (3) in the Investment Banks Or Brokers industry is in the same range as MS (7). This means that NMR’s stock grew similarly to MS’s over the last 12 months.
MS's Price Growth Rating (9) in the Investment Banks Or Brokers industry is somewhat better than the same rating for NMR (43). This means that MS’s stock grew somewhat faster than NMR’s over the last 12 months.
NMR's P/E Growth Rating (19) in the Investment Banks Or Brokers industry is in the same range as MS (28). This means that NMR’s stock grew similarly to MS’s over the last 12 months.
| MS | NMR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 51% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 56% | 2 days ago 56% |
| Momentum ODDS (%) | N/A | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 78% | N/A |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 60% |
| Advances ODDS (%) | 8 days ago 65% | 8 days ago 64% |
| Declines ODDS (%) | 14 days ago 58% | 28 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 52% | 2 days ago 57% |
| Aroon ODDS (%) | 2 days ago 50% | 2 days ago 59% |
A.I.dvisor indicates that over the last year, MS has been closely correlated with GS. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if MS jumps, then GS could also see price increases.